3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
133
Phase 2
16
Phase 1
16
Phase 1/2
6
Phase 4
3
Phase EARLY_PHASE1
2
Phase 3
2
Status
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
2
Dermatologic
1
Conditions
Breast Neoplasms
2
Melanoma
1
Interventions
Dexamethasone
13
Saline Solution
8
Bupivacaine
8
Bevacizumab
8
Tobacco Use Cessation Devices
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
7
Lenalidomide
7
Fluorouracil
7
pembrolizumab
6
Rituximab
6
Prednisone
6
Letrozole
6
Carboplatin
6
Propofol
5
Human Papillomavirus Recombinant Vaccine nonavalent
5
trametinib
4
lenvatinib
4
dabrafenib
4
cabozantinib
4
anlotinib
4
Trastuzumab
4
Tamoxifen
4
Standard of Care
4
Sodium Chloride
4
Ropivacaine
4
Paclitaxel
4
Immune Checkpoint Inhibitors
4
Esomeprazole
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 4
×
Blood Specimen Collection
×
1 year
×
Clear all
NCT06274515
2026-05-06
REMERGE
Hoffmann-La Roche
Phase 4
Recruiting
320 enrolled
NCT07490509
2026-04-01
DOSABEMA
Poitiers University Hospital
Phase 4
Not yet recruiting
235 enrolled
NCT02626065
2025-09-15
PAIR
Hospices Civils de Lyon
Phase 4
Completed
32 enrolled